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DOI: http://dx.doi.org/10.1016/j.hemonc.2013.02 .004 Isolated isochromosome 17q has rarely been reported in hematologic tumor patients. A 37-year-old man 
was admitted with fever and weakness. Blood routine test showed anemia and thrombocytopenia. The mor- 
phology and immunology of bone marrow cells conform to classic acute promyelocytic leukemia (APL). But 
the karyotype showed isolated isochromosome 17q without t(15;17) (q22;q12). Rverse transcriptase poly- 
merase chain reaction (RT-PCR) for PML -RARa was negative and fluorescence in situ hybridization (FISH)
analysis showed no RARa gene rearrangements.The patient responded poorly to all trans retinoic acid and 
traditional chemotherapy with daunorubicin and cytarabine and survived only 43 days after diagnosis. The 
pathogenesis and the best treatment choice for this kind of patients are not clear currently.Acute promy elocytic leuk emia (APL) is a dis- tinct subtyp e of acu te myelo id leuk emia that is characte rized by predomin ant prom yelo- 
cy tes and a chromos ome translo cation of t(15;17)
(q22;q12) which forms the fusion gene PML/ RAR a.
How ever, oth er kind s of chromo some transloca tion 
and RAR a rearran gement in addit ion to PML/ 
RA Ra can be detected in a minor ity of APL patients .
He re we report a rare case with typical acute promy- 
elo cytic leuk emia morp hology associated with isolated 
isoch romoso me 17q withou t RAR a rearran gement 
who responded poor ly to ATRA (all-trans retinoic 
acid ).CASE
A 37-y ear-old man presente d on February 21, 2011 
with a 20-day histo ry of feve r and we akness. On phys- 
ical examina tion, he was pale bu t no lymph nodes 
we re enlar ged. He had sever al ecchymos es on the Herigh t arm and a bloo d callus on the outside of the 
righ t geisoma. Ther e we re various herpes around his 
mo uth but no other sign iﬁcant ﬁndings. Routine 
blood test sh owed hemoglo bin 5.8 g/ dL, white blood 
cell count 6.57 · 109/L, and platelet count was 
7 · 109/L. Peripheral smear showed a great 
quantity of promyelocy tes.
Coag ulation proﬁle re vealed PT 9.9S(10.5-15),
IN R 0.7 (0.8–1.2) APTT 22.2S (24–38), FBG 
2.7 g/L (2–4). Serum LDH (lactate dehydro genase)
was increased to 506 U/L (0–250). Bone marrow 
sm ear showed a hypercell ular marr ow with 90% neo- 
pl astic promyelo cytes with cytoplasmic hyper granula- 
tion (Figure 1A ).
The cyto chemica l staining sh owed the cells were 
positiv e for myelope roxidas e, periodic acid-Schiff 
reac tion, and no n-speciﬁc esterase . The inhabita tion 
rate of sodium ﬂuoride was less than 20%. Immuno- 
phen o typing analysis showed bone marro w cells were 
positiv e for CD33 , CD13, and CD64 ; negativ e for matol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncste m.edmgr .com 
Figure 1A. Bone marrow smear at onset. Hypergranular promyelocytes accounted for 90% of nucleated cell. (Wright staining; original 
magnificati on 1000 ·.)
Figure 1B. Bone marrow smear after one course of ATRA and DA chemotherapy . There was still a predominance of promyelocytes . (Wright
staining; original magnificati on 1000 ·.)
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CD19. The patient was diagnose d with APL. The 
karyotyp e of G banding sh owed 46, XY, i(17)(q10)
(Fi gure 2). Reve rse transcripta se polym erase chai n
reactio n for PML–RAR a was negative: (PML–
RARa–bcr1/ABL = 0, ML–RAR a–bcr2/ABL = 0,
PML–RAR a–bcr3/ABL = 0).
Furthermor e, no RAR a gene rearran gements were 
detected with FISH (ﬂuorescence in situ hybri diza- 
tion) analy sis (Figure 3). For inducti on therapy the 
patient was treate d with a course of ATRA (all-trans
retinoic acid ) and che motherapy of DA re gimen (dau- 
norubi cin 60 mg /d · 4 days and cytarab ine 200 mg/ 
d · 7 days) but he re sponded poorly. After one course Hematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncst em.edmgr .com of inducti on, hypergr anular prom yelocyt es still ac- 
counte d for mo re than 90% of nucleate d bone marr ow 
cells (Fi gure 1B ). The patient was then give n a course 
of reinduc tion chemo therapy with medi al-dose cytara -
bine (2 g q 12 h · 3 day) bu t di ed soon after of intra- 
cranial bleeding .DISCUSSION
Acute prom yelocytic leukemia (APL) is cha racter- 
ized by the t(15;17) that generate s the PML–
RARa fusion gene and predicts a beneﬁcial re- 
sponse to all-tra ns retinoic acid . A mino rity of 
APL case s lacking the class ic t(15;17) may carry 43
Figure 2. Karyotype of G banding showing 46, XY , i(17), q(10).
Figure 3. Interphase nuclei FISH with RAR a dual-colo r separation probe at the initial diagnosis showing no RAR a rearrangemen t. (Fusion signal 
showing yellow color or green–red overlying color represen ts normal RAR a gene, separated signal of red from green represents RAR a
rearrangement.)
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NP M/RAR a, NuM A/RA Ra and PLZ F/RAR a.
How ever, in 2000, the European Working Party 
re ported ﬁve APL patients withou t RAR a rear-Herange ment with molecula r analys es which indicate 
that altern ative mechanis ms coul d mediate the dif- 
fe rentiation block that typiﬁes this disea se.1
Wheth er they are sensitiv e to ATRA therapy is not matol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncste m.edmgr .com 
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currently clear. Hor i et al. reviewe d eight AP L pa- 
tients with out RAR a rearran gement. ATRA treat- 
ment was effective for only one of them , not 
effectiv e for two cases, while the data of the other ﬁve
cases were not evaluab le.2
An isoch romosome of the long arm of the deriva- 
tive chromos ome 17 is rarely observed in APL pa- 
tients.3–7 In 2010, Ma nola et al. reported four cases 
of APL with der(17)(q10) t(15;17) and conducted a
literatu re review of 53 cases. Thes e patients were 
demon strated to accompa nied by an extra copy of 
RARa–PML with molecula r cyto genetic analy sis.3
The progno stic signiﬁcance of ider(17q) and the 
two copies of RAR a–PML as a consequen ce of 
ider(17q) in AP L patients are not clear curre ntly.
The data of Ma nola et al. showed no advers e inﬂuence 
of ider(17) on prognos es of APL patie nts treate d with 
ATRA and che motherapy .3 However, from the data 
of the same review, Tong et al. found that APL pa- 
tients with ider(17)(q10) t(15;17) who were not trea- Hematol Oncol Stem Cell Ther 6(1) First Quarter 2013 hemoncst em.edmgr .com ted with AT RA surv ived up to 10 years post- 
diagnosis. However, no patient treated with ATRA 
was re ported to live more than 4 years post-di agno- 
sis.7 Thes e ﬁndings indicate that ATRA does not im- 
prove prognos is of APL with ider(17)(q10).7
APL patients with isolated i(17q) withou t t(15;17)
are ev en rar er. The re were on ly two such case s in past 
literatu re.8,9 One of these case s did not go into remis -
sion and surv ived less than a year. Data of the other 
were not evaluable fro m the refe rence. In our repo rt,
the morpho logy and immun ology of bone marro w
cells co nform to classic AP L. Kar yotype analysis re- 
vealed isolated ider (17)(q10) withou t t(15;17), RT- 
PCR showed no PML–RAR a, and FISH analy sis 
showed no RAR a gene rearr angement. The patie nt 
had a poor resp onse to ATRA and to traditiona l che -
motherapy with daunorubic in and cytarab ine, and 
survived on ly 43 days af ter diagnosis. The path ogene- 
sis and the best treatm ent choice for this patient’s
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